A&A 正方反方辩论:无阿片类药物麻醉与常规阿片类药物麻醉在全身麻醉患者中的比较
本文为A&A正方反方辩论文章,正方主张围术期整合无阿片类药物麻醉(OFA)技术,认为可显著减少术后恶心呕吐(PONV)且镇痛效果与常规阿片类技术相当;反方指出OFA增加心动过缓、低血压和恢复时间延长等不良事件风险,且方案缺乏标准化、定义不一、结局评估时限有限,并认为术中减少阿片使用未必转化为出院时阿片处方减少。
要点
- 正方认为OFA可显著降低PONV且镇痛效果与常规阿片技术相当。
- 反方指出OFA增加心动过缓、低血压和恢复时间延长等不良事件风险。
- OFA方案缺乏标准化且定义不一,影响比较与推广。
核心结论
- 正方主张围术期整合OFA技术以获益,反方对OFA相关不良事件风险与方案标准化不足表示担忧。
研究设计与样本
- 本文为A&A正方反方辩论评论文章,正方与反方分别陈述观点并引用Meta分析与大型随机对照试验证据。
主要发现
- Meta分析显示OFA方案有效降低PONV发生率,尽管方案与手术人群存在差异。
- OFA技术提供有效疼痛控制,镇痛结局常与常规阿片技术相当。
- 大型随机对照试验显示OFA方案与心动过缓、低血压和恢复时间延长等不良事件风险增加相关。
- OFA减少术中阿片使用,但不一定转化为出院时阿片处方减少。
临床怎么用
- 临床决策需权衡OFA降低PONV的获益与心动过缓、低血压及恢复时间延长的风险。
- 实施OFA时应关注方案标准化与定义统一,并评估出院时阿片处方情况。
局限性
- OFA方案缺乏标准化且定义存在变异性,增加比较与推广难度。
- 结局评估时限有限,可能影响对OFA长期获益与风险的判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
See Article, page 16 In this Pro-Con commentary article, the Pro perspective advocates for the integration of opioid-free anesthesia (OFA) techniques in perioperative care, highlighting their benefits, including significant reductions in postoperative nausea and vomiting (PONV). Meta-analyses have shown that OFA protocols effectively reduce PONV rates despite variability in protocols and surgical populations. Furthermore, OFA techniques provide effective pain control, often demonstrating analgesic outcomes comparable to conventional opioid-based techniques. Conversely, the Con perspective raises concerns about the increased risk of adverse events associated with OFA protocols, such as bradycardia, hypotension, and prolonged recovery times, as evidenced by large randomized controlled trials. Critics emphasize the lack of standardization in OFA protocols, variability in definitions, and limited timeframe for outcome assessment, which complicates comparisons and generalizability. Additionally, they point out that while OFA reduces intraoperative opioid use, it does not necessarily translate into decreased opioid prescribing at discharge, a key factor in addressing persistent opioid use.
引用
- Cao S, Daniels M, Hah JM, et al. A&A Pro-Con Debate: Opioid-Free Versus Opioid-Conventional for Patients Undergoing General Anesthesia. Anesth Analg. 2025. PMID: 41201348. doi:10.1213/ANE.0000000000007800
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。